1Nozaki C, Saitoh A, Tamura N, et al. Antinocieeptive effect of oxycodone in diabetic mice[J]. Eur J Pharmacol, 2005,524( 1-3):75-79.
2Matthes HW, Maldonado R, Simonin F, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid receptor gene [J]. Nature, 1996,383 (6603): 819-823.
3De Schepper HU, Cremonini F, Park M1, et al. Opioids and the gut: pharmacology and current clinical experience[J]. Neurogastroenterol Motil, 2004,16(4):383-394.
4Kamp EH, Jones RC W, Tillman SR, et al. Quantitative assessment and characterization of visceral nociception and hyperalgesia in mice [J]. Am J Physiol Gastrointest. liver Physiol, 2003 284 (3):G434-G444.
5Eisenach JC, Carpenter R, Curry R. Analgesia from a peripherally active kappa-opioid receptor agonist in patienls with chronic pancreatitis[J]. Pain, 2003,101 (1-2):89-95.
6Gaveriaux-Ruff C, Kieffer BL. Opioid receptor genes inactivated in mice: the highlights[J]. N europeptides, 2002,36(2-3):62-71.
7Hermos JA, Young MM, Gagnon DR, et al. Characterization of longterm oxycodone/aceteminophen prescriptions in veteran patients[J]. Arch Interm Med, 2004,164(22):2361-2366.
8金有豫.治疗学的药理学基础[M].10版.北京:人民卫生出版社,2004:447-449.
9Ohquist G, Lindh A, Oja M, et al. Oxycodone and ketobemidone for oral premedication[J]. J Ambul Surg, 2004,10:185-189.
4Nonaka S, Kawaguchi Y, Oda I, et al.Safety and effective- ness of propofol-based monitored anesthesia care without in- tubation during endoscopic submucosal dissection for early gastric and esophageal cancers [ J ]. Dig Endosc, 2015, 27 (6) : 665-673.
5Park WY, Shin YS, Lee SK, et al. Bispectral index monitoring during anesthesiologist-directed propofol and remifentanil sedation for endoscopic submucosal dissection: a prospective randomized controlled trial [ J ]. Yonsei Med J, 2014,55(5) : 1421-1429.
6Zhang L, Chen C, Wang L,et al.Awakening from anesthesia using propofol or sevoflurane with epidural block in radical surgery for senile gastric cancer [ J ]. Int J Clin Exp Med, 2015, 8(10) : 19412-19417.
7Wang ZT, Gong HY, Zheng F, et al. Propofol suppresses proliferation and invasion of gastric cancer cells via downreg- ulation of microRNA-221 expression [ J ]. Genet Mol Res, 2015,14(3) :8117-8124.
8Gotoda T, Kusano C, Nonaka M, et al. Non-anesthesiologist administrated propofol ( NAAP ) during endoscopic submucosal dissection for elderly patients with early gastric cancer[ J] .Gastric Cancer,2014,17(4) :686-691.
9Khoronenko VE, Shemetova MM, Drozhzhina OV, Anaesthesia and intensive care during intraoperative intraper- itoneal hyperthermic chemotherapy in patients with gastric cancer (literature review and own clinical experience) [ J]. Anesteziol Reanimatol, 2015,60 ( 1 ) : 50-54.
10Nakanuno R, Yasuda T, Hamada H, et al. Propofol for anes- thesia and postoperative sedation resulted in fewer inflamma- tory responses than sevoflurane anesthesia and midazolam se- dation after thoracoabdominal esophagectomy [ J ]. Hiroshima J Med Sci,2015,64(3) :31-37.
